Search Results
The prognostic impact of TP53 mutation in MPNs
The prognostic impact of TP53 and IgHV status in the era of targeted therapies in CLL
Why MPNs Transform to AML
The impact of TP53 mutation on treatment approaches in MCL
Myelofibrosis: Considering TP53 and Post-MPN AML
Immunological impact of TP53 in MDS
An analysis of TP53 mutation in AML and HR-MDS
Impact of TP53 mutations on outcomes in myelofibrosis
Dr. Jason Gotlib, MD, MS - Molecular Mutations in MPNs: Impact on Treatment
The impact of p53 mutation on survival in EGFR-mutated NSCLC patients
Why MPN transforms to AML
Pathogenic TP53 Mutations Associated With Poor Prognosis in Pediatric AML
